Antibacterial treatment of aspiration pneumonia in older people: a systematic review
- PMID: 30464429
- PMCID: PMC6214417
- DOI: 10.2147/CIA.S183344
Antibacterial treatment of aspiration pneumonia in older people: a systematic review
Abstract
Background: Aspiration pneumonia is a common problem in older people with high mortality and increasing prevalence.
Objective: The aims of this paper were to systematically review the literature on the antibacterial treatment of aspiration pneumonia in elderly patients and identify the microbiology of aspiration pneumonia.
Materials and methods: EMBASE, MEDLINE, and Cochrane databases were systematically searched for studies that examined the clinical efficacy of antibiotic treatment in elderly patients with aspiration pneumonia. Information on study design, antibiotic treatment, study population, participants, microbiology, clinical outcomes, adverse events, and mortality was recorded.
Results: There were no definitive clinical trials, placebo-controlled trials, or meta-analyses. Of the eight studies selected for inclusion in the review, the majority utilized and/or compared broad-spectrum antibiotics. No specific antibacterial agent had evidence of superior efficacy. Broad-spectrum antibiotics resulted in the emergence of multiresistant organisms. Anaerobic bacteria were infrequently isolated, suggesting a less important role in the pathogenesis of aspiration pneumonia.
Conclusion: There is limited evidence with regard to the use of antibiotics in older patients with aspiration pneumonia. Research providing an evidence base for the treatment of aspiration pneumonia in older people is required.
Keywords: antibacterial; antibiotics; antimicrobial; aspiration pneumonia; older people.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
-
- Mier L, Dreyfuss D, Darchy B, et al. Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures. Intensive Care Med. 1993;19(5):279–284. - PubMed
-
- Allewelt M, Schüler P, Bölcskei PL, Mauch H, Lode H, Study Group on Aspiration Pneumonia Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin Microbiol Infect. 2004;10(2):163–170. - PubMed
-
- Kadowaki M, Demura Y, Mizuno S, et al. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients. Chest. 2005;127(4):1276–1282. - PubMed
-
- Ott SR, Allewelt M, Lorenz J, Reimnitz P, Lode H, German Lung Abscess Study Group Moxifloxacin vs ampicillin/sulbactam in aspi ration pneumonia and primary lung abscess. Infection. 2008;36(1):23–30. - PubMed
-
- Talaie H, Jabari HR, Shadnia S, Pajouhmand A, Nava-Ocampo AA, Youssefi M. Cefepime/clindamycin vs. ceftriaxone/clindamycin for the empiric treatment of poisoned patients with aspiration pneumonia. Acta Biomed. 2008;79(2):117–122. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical